Barbara D. Lovász

Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009

Péter L. Lakatos, Petra A. Golovics, Gyula Dávid et al. · The American Journal of Gastroenterology · 2012 · 212 citations

Medicine, Clinical Sciences, Surgery +9

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort

K Gecse, Barbara D. Lovász, Klaudia Farkas et al. · Journal of Crohn s and Colitis · 2015 · 183 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +12

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

László Kiss, Tamás Szamosi, Tamás Molnár et al. · Alimentary Pharmacology & Therapeutics · 2011 · 160 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Is Current Smoking Still an Important Environmental Factor in Inflammatory Bowel Diseases? Results from a Population-based Incident Cohort

Péter L. Lakatos, Zsuzsanna Végh, Barbara D. Lovász et al. · Inflammatory Bowel Diseases · 2013 · 103 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +11

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohnʼs disease: A marker for patient classification?

Lajos S. Kiss, Mária Papp, Barbara D. Lovász et al. · Inflammatory Bowel Diseases · 2011 · 89 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17